Market Place
Sourcing Support
United Therapeutics to Present at UBS Global Health Conference
05 Nov 2024 //
BUSINESSWIRE
United Therapeutics Reports Q3 2024 Financial Results
30 Oct 2024 //
BUSINESSWIRE
1. United Therapeutics Q3 2024 Financial Results on October 30
23 Oct 2024 //
BUSINESSWIRE
United Therapeutics Reaches 500th Lung Transplant Milestone
23 Oct 2024 //
BUSINESSWIRE
United Therapeutics to Feature Data at CHEST 2024 Meeting
24 Sep 2024 //
BUSINESSWIRE
Sandoz And Liquidia Win $137M Against United In Remodulin Dispute
16 Sep 2024 //
FIERCE PHARMA
United Therapeutics Publishes 2024 Responsibility Report
10 Sep 2024 //
BUSINESSWIRE
United Therapeutics Corporation to Present at Upcoming Investor Conferences
28 Aug 2024 //
BUSINESSWIRE
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
31 Jul 2024 //
BUSINESSWIRE
United Therapeutics To Report Q2 2024 Results On July 31
24 Jul 2024 //
BUSINESSWIRE
United Therapeutics Fully Enrolls TETON 2 Study For Inhaled Treprostinil
10 Jul 2024 //
BUSINESSWIRE
United Therapeutics Corporation Announces Election of Jan Malcolm to its BOD
27 Jun 2024 //
BUSINESSWIRE
Tempus Collaborates with United on AI for Pulmonary Hypertension Risk Detection
25 Jun 2024 //
BUSINESSWIRE
United Therapeutics: Presenting At Goldman Sachs Healthcare Conference
05 Jun 2024 //
BUSINESSWIRE
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
01 May 2024 //
BUSINESSWIRE
United Therapeutics Reports Q1 2024 Results on May 1
24 Apr 2024 //
BUSINESSWIRE
United Therapeutics` First Xenothymokidney Transplant Success
24 Apr 2024 //
BUSINESSWIRE
Par Pharma recalls blood pressure med for possible contamination
22 Apr 2024 //
FIERCE PHARMA
United Therapeutics Showcasing Data At ATS 2024
16 Apr 2024 //
BUSINESSWIRE
United Therapeutics the First Comprehensive Review Publication
26 Mar 2024 //
BUSINESSWIRE
FDA approves Johnson & Johnson`s combo pill Opsynvi for PAH
26 Mar 2024 //
FIERCE PHARMA
United Therapeutics Announces $1 Billion Accelerated Share Repurchase Program
25 Mar 2024 //
BUSINESSWIRE
United Therapeutics to Take Lung-Drug Patent Fight to High Court
15 Mar 2024 //
BLOOMBERG
United Therapeutics to Present at Leerink Partners Biopharma Conference 2024
05 Mar 2024 //
BUSINESSWIRE
United Therapeutics to Present at TD Cowen 44th Annual Health Care Conference
27 Feb 2024 //
BUSINESSWIRE
United Therapeutics Commences Litigation to Ensure Fairness in Review Process
21 Feb 2024 //
PRESS RELEASE
United Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 //
PRESS RELEASE
United Therapeutics to Report Fourth Quarter & Full Year 2023 Financial Results
14 Feb 2024 //
BUSINESSWIRE
United Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
29 Dec 2023 //
BUSINESSWIRE
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer
13 Dec 2023 //
BUSINESSWIRE
United Therapeutics and Miromatrix Medical Announce Successful Tender Offer
12 Dec 2023 //
BUSINESSWIRE
United Therapeutics Named as One of America’s Most Responsible Companies 2024
07 Dec 2023 //
BUSINESSWIRE
Miromatrix Reports Third Quarter 2023 Results
14 Nov 2023 //
GLOBENEWSWIRE
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
01 Nov 2023 //
BUSINESSWIRE
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
31 Oct 2023 //
BUSINESSWIRE
United Announces First Patient Enrolled in Phase 3 Study of Nebulized Tyvaso
31 Oct 2023 //
BUSINESSWIRE
United Therapeutics to Acquire Miromatrix Medical
30 Oct 2023 //
PRESS RELEASE
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results
25 Oct 2023 //
BUSINESSWIRE
Miromatrix to Present at the 2023 ISODP Organ Donation Congress
11 Oct 2023 //
GLOBENEWSWIRE
Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa
05 Oct 2023 //
GLOBENEWSWIRE
United Therapeutics Announces Recent Milestones for Xenotransplantation Programs
22 Sep 2023 //
BUSINESSWIRE
United Issues its 2023 Corporate Responsibility and Public Benefit Report
12 Sep 2023 //
BUSINESSWIRE
Miromatrix Announces Participation in the ARM Tissue Engineering Workshop
05 Sep 2023 //
GLOBENEWSWIRE
United Therapeutics to Present at the Morgan Stanley 21st Annual Conference
01 Sep 2023 //
BUSINESSWIRE
Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update
14 Aug 2023 //
GLOBENEWSWIRE
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
02 Aug 2023 //
BUSINESSWIRE
United Therapeutics Corporation to Report Second Quarter 2023 Financial Results
26 Jul 2023 //
BUSINESSWIRE
Miromatrix to Report Second Quarter 2023 Financial Results
25 Jul 2023 //
GLOBENEWSWIRE
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
24 Jul 2023 //
BUSINESSWIRE
Miromatrix Poster Voted Best in Congress at 2023 American Transplant Congress
13 Jul 2023 //
GLOBENEWSWIRE
United Therapeutics sheds 5.3% this week, as yearly returns fall more in line
10 Jul 2023 //
YAHOO FINANCE
Liquidia and United Therapeutics could bring new lung indication into legal saga
29 Jun 2023 //
ENDPTS
United Therapeutics Unveils Net Zero Energy Distribution Center
14 Jun 2023 //
BUSINESSWIRE
United Therapeutics Corporation Reports First Quarter 2023 Financial Results
03 Jun 2023 //
PRESS RELEASE
Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role
01 Jun 2023 //
GLOBENEWSWIRE
Miromatrix Announces Participation in the 20th Annual Craig-Hallum Conference
30 May 2023 //
GLOBENEWSWIRE
Miromatrix Presenting at the 2023 American Transplant Congress
30 May 2023 //
GLOBENEWSWIRE
Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update
11 May 2023 //
GLOBENEWSWIRE
Miromatrix to Report First Quarter 2023 Financial Results
27 Apr 2023 //
GLOBENEWSWIRE
United Therapeutics Corporation to Report First Quarter 2023 Financial Results
26 Apr 2023 //
BUSINESSWIRE
